XML 50 R20.htm IDEA: XBRL DOCUMENT v3.25.1
Stock Options
 12 Months Ended
Dec. 31, 2024
Stock Options [Abstract]  
STOCK OPTIONS

13. STOCK OPTIONS

 

The Company has not granted any options during years ended December 31, 2024 and 2023. The Company’s most recent option grant was in 2022 that 76,190 shares (post-split) of common stock were granted to employees and certain consultants. The weighted average grant date fair value of options granted in 2022 was $27.9 (post-split). There are 386,021 options available for grant under the 2016 Equity Incentive Plan as of December 31, 2024. Compensation costs associated with the Company’s stock options are recognized, based on the grant-date fair values of these options over vesting period. As of December 31, 2024 and 2023, there were no unvested options.

 

Options issued and outstanding as of December 31, 2024, and their activities during the year then ended are as follows:

 

          Weighted-     Weighted-        
          Average     Average        
    Number of     Exercise     Contractual      
    Underlying
Shares
(post-split)		     Price
Per Share (post-split)		     Life
Remaining
in Years		     Aggregate
Intrinsic
Value		  
Outstanding as of January 1, 2024     258,710     $ 27.9       7.74                    -  
Granted     -       -       -       -  
Forfeited     -       -       -       -  
Outstanding as of December 31, 2024     258,710       27.9       7.74     $ -  
Exercisable as of December 31, 2024     258,710       27.9       7.74     $ -  
Vested and expected to vest     258,710     $ 27.9       6.74     $ -